381 related articles for article (PubMed ID: 23604128)
1. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
Barckhausen C; Roos WP; Naumann SC; Kaina B
Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
[TBL] [Abstract][Full Text] [Related]
3. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
Wang G; Dombkowski A; Chuang L; Xu XX
Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells.
Shen YH; Chen BR; Cherng SH; Chueh PJ; Tan X; Lin YW; Lin JC; Chuang SM
Toxicol Lett; 2011 Sep; 205(3):341-50. PubMed ID: 21742020
[TBL] [Abstract][Full Text] [Related]
5. Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.
Chueh FS; Chen YL; Hsu SC; Yang JS; Hsueh SC; Ji BC; Lu HF; Chung JG
Oncol Rep; 2013 Feb; 29(2):613-8. PubMed ID: 23233170
[TBL] [Abstract][Full Text] [Related]
6. DDB2 decides cell fate following DNA damage.
Stoyanova T; Roy N; Kopanja D; Bagchi S; Raychaudhuri P
Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10690-5. PubMed ID: 19541625
[TBL] [Abstract][Full Text] [Related]
7. p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53, localize to sites of UV-irradiation-induced DNA damage, in vivo.
Fitch ME; Cross IV; Ford JM
Carcinogenesis; 2003 May; 24(5):843-50. PubMed ID: 12771027
[TBL] [Abstract][Full Text] [Related]
8. Cross-resistance to death ligand-induced apoptosis in cisplatin-selected HeLa cells associated with overexpression of DDB2 and subsequent induction of cFLIP.
Sun CL; Chao CC
Mol Pharmacol; 2005 Apr; 67(4):1307-14. PubMed ID: 15644494
[TBL] [Abstract][Full Text] [Related]
9. Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients.
Lai TC; Chow KC; Fang HY; Cho HC; Chen CY; Lin TY; Chiang IP; Ho SP
Oncol Rep; 2011 May; 25(5):1243-51. PubMed ID: 21327329
[TBL] [Abstract][Full Text] [Related]
10. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
11. Human three prime exonuclease TREX1 is induced by genotoxic stress and involved in protection of glioma and melanoma cells to anticancer drugs.
Tomicic MT; Aasland D; Nikolova T; Kaina B; Christmann M
Biochim Biophys Acta; 2013 Aug; 1833(8):1832-43. PubMed ID: 23578789
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma.
Fautrel A; Andrieux L; Musso O; Boudjema K; Guillouzo A; Langouët S
J Hepatol; 2005 Aug; 43(2):288-93. PubMed ID: 15922480
[TBL] [Abstract][Full Text] [Related]
13. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
Li W; Melton DW
Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
[TBL] [Abstract][Full Text] [Related]
15. Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair.
Budden T; Davey RJ; Vilain RE; Ashton KA; Braye SG; Beveridge NJ; Bowden NA
Oncotarget; 2016 Sep; 7(38):60940-60953. PubMed ID: 27487145
[TBL] [Abstract][Full Text] [Related]
16. Translesion polymerase η is upregulated by cancer therapeutics and confers anticancer drug resistance.
Tomicic MT; Aasland D; Naumann SC; Meise R; Barckhausen C; Kaina B; Christmann M
Cancer Res; 2014 Oct; 74(19):5585-96. PubMed ID: 25125662
[TBL] [Abstract][Full Text] [Related]
17. Differentiating human keratinocytes are deficient in p53 but retain global nucleotide excision repair following ultraviolet radiation.
Oh DH; Yeh K
DNA Repair (Amst); 2005 Sep; 4(10):1149-59. PubMed ID: 16043423
[TBL] [Abstract][Full Text] [Related]
18. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression.
Wu YH; Wu TC; Liao JW; Yeh KT; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10422-32. PubMed ID: 21056989
[TBL] [Abstract][Full Text] [Related]
19. Proficient global nucleotide excision repair in human keratinocytes but not in fibroblasts deficient in p53.
Ferguson BE; Oh DH
Cancer Res; 2005 Oct; 65(19):8723-9. PubMed ID: 16204041
[TBL] [Abstract][Full Text] [Related]
20. The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation.
Wang G; Chuang L; Zhang X; Colton S; Dombkowski A; Reiners J; Diakiw A; Xu XS
Nucleic Acids Res; 2004; 32(7):2231-40. PubMed ID: 15107491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
